Skip to main content
Clinical Trials/NCT03244878
NCT03244878CompletedNot Applicable

Randomized Controlled Trial of a Culturally-adapted Version of Thrive, a Computerized Cognitive Behavior Therapy (cCBT) Program to Treat Depressive Symptoms, Syndromes, and Disorders Among Rural Montanans

Montana State University1 site in 1 country464 target enrollmentStarted: May 1, 2017Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
464
Locations
1
Primary Endpoint
Patient Health Questionnaire-9

Study Overview

Brief Summary

This study evaluates a culturally-modified version of Thrive, a computerized Cognitive Behavior Therapy program to treat depressive symptoms, syndromes, and disorders among rural Montanans. Study participants will be randomized to either a wait-list treatment as usual or the Thrive program. After 8 weeks, the wait-list group will then receive Thrive. The primary assessment measure is the Patient Health Questionnaire-9.

Detailed Description

Montana ranks high among states on mental health disorder prevalence and low on access to mental health care. It has the highest suicide rate in the nation. Of Montana's 56 counties, 10 are classified as rural and 45 as frontier, accentuating distance challenges in accessing care. New treatment delivery modalities are needed to complement, supplement and augment traditional mental health care. With increase in access to the Internet, computer-administered Cognitive Behavior Therapy (cCBT) programs have emerged as viable approaches to effective treatment of depression.

Thrive is an interactive cCBT program with a heavy emphasis on video rather than text content that appears to improve participant engagement, a shortcoming seen in prior cCBT programs.

The goal of this project is to conduct a randomized wait-list controlled of Thrive to determine its effectiveness in reducing depressive symptom severity among Montanans, many of whom have few or no other options for mental health treatment.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Aged 18 years or older
  • •Baseline PHQ-9 score of 5 or greater
  • •Montana resident
  • •Regular access to broadband internet (streaming capability)

Exclusion Criteria

  • •No broadband internet access
  • •Aged 17 years or younger
  • •Does not have Montana residency
  • •Baseline PHQ-9 score of < 5

Arms & Interventions

Intervention - Thrive program

Experimental

Participants will receive access to the Thrive program for 8 weeks

Intervention: Thrive (Behavioral)

Wait-list Control

No Intervention

Participants will have no access to the Thrive program for 8 weeks upon enrollment. They will receive a link to the NIMH website to read about information on depression.

Outcomes

Primary Outcomes

Patient Health Questionnaire-9

Time Frame: 2 weeks

Clinical measure of depressive symptom severity. Self-reported with a score range from 0 to 3 (not at all to nearly every day)

Secondary Outcomes

  • Generalized Anxiety Disorder-7(2 weeks)
  • Work and Social Adjustment Scale(1 year)
  • Connor-Davidson Resilience Scale(1 month)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Mark B. Schure, Ph.D.

Assistant Professor

Montana State University

Study Sites (1)

Loading locations...

Similar Trials